Clinical Trial Update: Ketones in Heart Failure With Reduced Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketone-based therapy for heart failure with reduced ejection fraction; enrollment is currently by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Duke University | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 2 | Status: ENROLLING_BY_INVITATION